Author:
Liang Zixi,Liu Zhen,Cheng Chao,Wang Hao,Deng Xiaojie,Liu Jiahao,Liu Chen,Li Yonghao,Fang Weiyi
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference40 articles.
1. Chua, M., Wee, J., Hui, E. P. & Chan, A. Nasopharyngeal carcinoma. Lancet 387, 1012–1024 (2016).
2. Petersson, F. Nasopharyngeal carcinoma: a review. Semin. Diagn. Pathol. 32, 54 (2015).
3. Lin, K. et al. Lack of association between the distribution of ABO blood groups and nasopharyngeal carcinoma in a population of Southern China. J. Cancer Res. Ther. 14, 785 (2018).
4. Tang, L. Q. et al. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 19, 461 (2018).
5. Coghill, A. E. et al. Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan. Clin. Cancer Res. 24, 1305 (2018).
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献